1Adam R, MeMaster P, O'grady JG, et al. Evolution of Liver Transplantation in Europe: Report of the European Liver Transplant Registry[J]. Liver Transpl,2003,9 : 1231-1243.
2Bernal W. Changing patterns of causation and the use of transplantation in the United kingdom[J]. Semin Liver Dis,2003,23:227-237.
3Marsh JW, Dvorchik I. Liver organ allocation for hepatoeellularcarcinoma; Are we sure[J]? Liver Transpl, 2003,9 : 1394-1403.
4Bigourdan JM, Jaeck D, Meyer N, et al. Small hepatocellularcar cinoma in Child A Cirrhotic patients: Hepatic Resection versus transplantation[J]. Liver Transpl, 2003,9 : 513-520.
5Hu RH, Ho MC, Wu YM, et al . Feasibility of salvage liver transplantation for patients with recurrent hepatoeellular carcinoma [J]. Clin Transplant, 2005,19 : 175-80.
6Pokorny H, Gnant M, Rasoul-Rockenschaub S, et al. Does additional doxorubicin chemotherapy improve outcome in patients with hepatocellular carcinoma treated by liver transplantation[J] ? Am J Transplant, 2005,5 : 788-794.
7Liver Failure and Artficial Liver Group,Chinese Society of Infectious Diseases,Chinese Medical Association.肝衰竭诊疗指南[J].实用肝脏病杂志,2006,9(6):321-324. 被引量：188
9Zheng SS,Xu X,Wu J,et al.Liver transplantation for hepatocellular carcinoma:Hangzhou experience[J].Transplantation,2008,85(12):1726-1732.
10Echaniz A,Pita S,Otero A,et al.Incidence,risk factors and influence on survival of infectious complications in liver transplantation[J].Enferm Infecc Microbiol Clin,2003,21(5):224.
